EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the Neurotherapeutic Effect of Quercetin on Neuronal miR‐124 and β‐Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) in an Experimental Alzheimer's Disease Model

Aly S Al-Sawasany, Hassan M Fayed, Bothaina F Mahmoud, Samar S Elblehi, Nesma A Ghazal iD

Journal of Biochemical and Molecular Toxicology · 2025

DOI: 10.1002/jbt.70290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Aly S Al-Sawasany und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt. Hauptthemen laut MEDLINE: Quercetin, Alzheimer Disease, MicroRNAs, Aspartic Acid Endopeptidases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is the most common cause of dementia, a neurodegenerative disorder that progress overtime, which is best known for mood swings and loss of cognitive, behavioral and functional abilities. Quercetin is one of the most consumed flavonoids in the diet and has neuroprotective, anti‐inflammatory and antioxidant effects. The purpose of this study was to assess the potential neurotherapeutic effect of quercetin and compare it with donepezil. 40 Wister male rats were used and separated into two main groups: Group I: control group; Group II: AD group, which was divided into four subgroups: Group IIA: untreated AD‐rats; Group IIB: quercetin treated AD‐rats; Group IIC: donepezil treated AD‐rats and Group IID: combined group of quercetin and donepezil. Hydrated aluminum chloride (AlCl 3 .6H 2 O) solution (75 mg/kg/day) was administered orally for 6 weeks to induce the AD‐like conditions. Morris water maze, behavior test, was used to monitor the cognitive function. Hippocampal tissues were excised for assessment of Alzheimer's parameters and blood samples were obtained for liver and kidney function assessment. According to the final findings, untreated rats presented significantly increased levels of amyloid β 1‐42 ; tau protein; malondialdehyde; nuclear factor kappa‐B; acetylcholinesterase activity, β‐site amyloid precursor protein cleaving enzyme 1 upregulation and miRNA‐124 downregulation. The best results of treatment were observed in the combination of donepezil and quercetin, as revealed by histopathological observations via H&E and Congo red stains. This study led to the conclusion that quercetin, by targeting several pathogenic pathways, could be used as an adjuvant drug with donepezil for AD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuercetinAlzheimer DiseaseMicroRNAsAspartic Acid EndopeptidasesAmyloid Precursor Protein SecretasesNeuronsNeuroprotective AgentsAnimalsMaleRatsDisease Models, AnimalRats, WistarDonepezilHippocampus

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid β1‐42miR‐124quercetinβ‐site amyloid precursor protein cleaving enzyme 1 and donepezil

Substanzen

QuercetinMicroRNAsBace1 protein, ratAspartic Acid EndopeptidasesAmyloid Precursor Protein SecretasesMIRN124 microRNA, ratDonepezilNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Biochemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt.
  • Department of Pathology, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt.

ORCID-Profile: Nesma A Ghazal

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Al-Sawasany, A. S., Fayed, H. M., Mahmoud, B. F., Elblehi, S. S., & Ghazal, N. A. (2025). Evaluation of the Neurotherapeutic Effect of Quercetin on Neuronal miR‐124 and β‐Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) in an Experimental Alzheimer's Disease Model. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70290

Vancouver

Al-Sawasany AS, Fayed HM, Mahmoud BF, Elblehi SS, Ghazal NA. Evaluation of the Neurotherapeutic Effect of Quercetin on Neuronal miR‐124 and β‐Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) in an Experimental Alzheimer's Disease Model. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70290

BibTeX
@article{AlSawasany2025,
  author = {Al-Sawasany, Aly S and Fayed, Hassan M and Mahmoud, Bothaina F and Elblehi, Samar S and Ghazal, Nesma A},
  title = {Evaluation of the Neurotherapeutic Effect of Quercetin on Neuronal miR‐124 and β‐Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) in an Experimental Alzheimer's Disease Model},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  doi = {10.1002/jbt.70290}
}
Kostenlos starten →